Alveolar hypoxia, alveolar macrophages, and systemic inflammation.
Diseases featuring abnormally low alveolar PO2 are frequently accompanied by systemic effects. The common presence of an underlying inflammatory component suggests that inflammation may contribute to the pathogenesis of the systemic effects of alveolar hypoxia. While the role of alveolar macrophages in the immune and defense functions of the lung has been long known, recent evidence indicates that activation of alveolar macrophages causes inflammatory disturbances in the systemic microcirculation. The purpose of this review is to describe observations in experimental animals showing that alveolar macrophages initiate a systemic inflammatory response to alveolar hypoxia. Evidence obtained in intact animals and in primary cell cultures indicate that alveolar macrophages activated by hypoxia release a mediator(s) into the circulation. This mediator activates perivascular mast cells and initiates a widespread systemic inflammation. The inflammatory cascade includes activation of the local renin-angiotensin system and results in increased leukocyte-endothelial interactions in post-capillary venules, increased microvascular levels of reactive O2 species; and extravasation of albumin. Given the known extrapulmonary responses elicited by activation of alveolar macrophages, this novel phenomenon could contribute to some of the systemic effects of conditions featuring low alveolar PO2.
Chao
Jie
J
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA. jchao@kumc.edu
Wood
John G
JG
Gonzalez
Norberto C
NC
D000818:Animals; D006801:Humans; D000860:Hypoxia / Q000473:pathology*; D007249:Inflammation / Q000473:pathology*; D007511:Ischemia / Q000473:pathology; D008171:Lung Diseases / Q000473:pathology; D008262:Macrophage Activation / Q000502:physiology; D016676:Macrophages, Alveolar / Q000473:pathology*; D051381:Rats